Curative Application of Immunotherapy in Untreated Head and Neck and Nasopharynx Cancer

Marshall Posner^{1

2}

Affiliations

¹ Tampa General Hospital Cancer Institute/Cancer Center of South Florida, Palm Springs.
² University of South Florida/Morsani Medical College, Palm Springs.

Comment

Marshall Posner. JAMA. 2025.

. 2025 May 13;333(18):1584-1585.

doi: 10.1001/jama.2025.3012.

Marshall Posner^{1

2}

¹ Tampa General Hospital Cancer Institute/Cancer Center of South Florida, Palm Springs.
² University of South Florida/Morsani Medical College, Palm Springs.

No abstract available

Comment on

Adjuvant PD-1 Blockade With Camrelizumab for Nasopharyngeal Carcinoma: The DIPPER Randomized Clinical Trial.
Liang YL, Liu X, Shen LF, Hu GY, Zou GR, Zhang N, Chen CB, Chen XZ, Zhu XD, Yuan YW, Yang KY, Jin F, Hu WH, Xie FY, Huang Y, Han F, Tang LL, Mao YP, Lu LX, Sun R, He YX, Zhou YY, Long GX, Tang J, Chen LS, Zong JF, Jin T, Li L, Lin J, Huang J, Gong XY, Zhou GQ, Chen L, Li WF, Chen YP, Xu C, Lin L, Huang SH, Huang SW, Wang YQ, Huang CL, Feng HX, Hou M, Chen CH, Zheng SF, Li YQ, Hong SB, Jie YS, Li H, Yun JP, Zang SB, Liu SR, Lin QG, Li HJ, Tian L, Liu LZ, Zhao HY, Li JB, Lin AH, Liu N, Zhang Y, Guo R, Ma J, Sun Y. Liang YL, et al. JAMA. 2025 May 13;333(18):1589-1598. doi: 10.1001/jama.2025.1132. JAMA. 2025. PMID: 40079940 Free PMC article. Clinical Trial.
Atezolizumab in High-Risk Locally Advanced Squamous Cell Carcinoma of the Head and Neck: A Randomized Clinical Trial.
Haddad R, Fayette J, Teixeira M, Prabhash K, Mesia R, Kawecki A, Dechaphunkul A, Dinis J, Guo Y, Masuda M, Hsieh CY, Ghi MG, Vaz de Melo Sette C, Harrington K, Tahara M, Saba NF, Lau A, Jiang T, Yan Y, Ballinger M, Kaul M, Matheny C, Cuchelkar V, Wong DJ. Haddad R, et al. JAMA. 2025 May 13;333(18):1599-1607. doi: 10.1001/jama.2025.1483. JAMA. 2025. PMID: 40079944 Free PMC article. Clinical Trial.